Glimepiride
Product Images NDC 70934-167

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 70934-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 167 90 Master Bottle Label Approval Rev A 06 19

Glimepiride Tablets, USP 2mg, bottle label for 90 tablets by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label shows the NDC 70934-167-90 and includes storage instructions and regulatory information. A secondary label panel lists product details including strength, manufacturer code, lot number, and expiration date placeholders for multiple batches.*

FDA Label Image

Structure (Glimepiride Structure)

Chemical structure diagram of Glimepiride showing its molecular composition with functional groups including a sulfonylurea moiety and multiple rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.